ArticleCancer immunology, immunotherapy : CII2016

Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer.

Federica Cappuccini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.